Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

desmethylcyproheptadine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The contribution of drug metabolites to cyproheptadine (CPH)-induced alterations in endocrine pancreatic β-cells was investigated… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
1993
1993
To investigate the pharmacokinetics of cyproheptadine (CPH) and its metabolites, the plasma concentration and urinary excretion… Expand
1988
1988
The effects of pretreatment with inhibitors of drug metabolism on the biotransformation of cyproheptadine (CPH) and the ability… Expand
1987
1987
The tissue distribution of unchanged drug and metabolites in pregnant rats was studied following oral administration of… Expand
1986
1986
The susceptibility of fetal endocrine pancreas to the diabetogenic action of cyproheptadine was investigated. Cyproheptadine (5… Expand
1985
1985
The role of a direct effect of serotonin (5-HT) on PRL secretion at the pituitary level is uncertain. The present study… Expand
1983
1983
The effects of cyproheptadine, desmethylcyproheptadine, serotonin, gamma-amino-butyric acid (GABA) and sodium valproate were… Expand
1983
1983
Cyproheptadine and its metabolite desmethylcyproheptadine were shown to suppress directly the release of adrenocorticotrophin… Expand
1974
1974
Desmethylcyproheptadine-10,11-epoxide, cyproheptadine-10,11-epoxide, and desmethylcyproheptadine were identified in rat urine… Expand
1973
1973
Abstract The ability of various compounds to induce pancreatic islet cell vacuolization in the rat was assessed… Expand